Evidence Synthesis: Short Implants and the Case for Splinting
Across seven reviews on this site — a 1,683-implant analytical review, two bench studies, a split-mouth trial and three meta-analyses — short and narrow implants survive at rates close to conventional fixtures. The catch is consistent: the failure moves off the bone and onto the prosthetic hardware, and splinting is the single most reliable lever.
Splint the short ones
Reviews synthesised · 7
- Short Implants Behaved Better in Pairs.
- Short Implants Still Have to Obey Physics
- Short Implants, Superior Stability: The Case for Going Wide Instead of Long
- Narrow Implants Held Up. The Screws Complained.
- Small Implants, Big Claims: Can Narrow-Diameter Fixtures Survive in the Posterior?
- Wide Implants, Minimal Fuss.
- Does Implant Diameter Actually Predict Prosthesis Complications? A Meta-Analysis Says: Not Really
Civil engineers settled an argument long ago that implant dentistry is still having: a short, stout column does not behave like a tall, slender one, and it rarely fails the way you feared it would. A squat pillar does not snap in the middle. It punches into whatever it is standing on, or it loosens at the joint where it meets the structure above. Short dental implants have been making the same quiet point for two decades, and seven reviews on this site have now said it loudly enough that it is worth gathering in one place. The short implant is not a weaker long implant. It is a different object, with a different failure mode, and most of that failure has migrated away from the bone-implant interface and onto the screw you tighten into it.
The evidence pulled together here runs from an analytical review of 1,683 implants and a bovine-rib finite element model, through a primary-stability bench test and a split-mouth narrow-versus-standard trial, to a 2,741-implant posterior meta-analysis, a six-year wide-implant series and a meta-analysis of diameter and prosthetic complications. They do not entirely agree, which is what makes the through-line worth trusting.
What the Studies Actually Showed
Start with survival, because the numbers are calmer than the profession’s anxiety about them. Block’s analytical review found single short implants failed at 7.3% (62 of 853), splinted short implants at 4.3% (36 of 830), and long implants at 1.9% (11 of 565). Splinting did not abolish the short-implant penalty, but it roughly halved it. The bovine-rib model explains the mechanism without a single patient: crown-to-implant (C/I) ratios climbed from 1.22 at 10 mm to 4.55 at 4 mm, peak bone stress (von Mises) rose from 9.1 to 27.6 MPa across that same range, and splinting produced a statistically significant reduction in micromotion for the 4 mm implants under load. One study counts failures; the other shows you why they happen.
Width turns out to be the lever that length cannot pull. On the bench, short wide implants (6.0 × 7 mm) beat conventional ones (3.75 × 10 mm) on insertion torque in both bone densities: 44.25 versus 34.00 Ncm in type 2 bone, 28.5 versus 16.25 Ncm in type 4 (both P < .0001). Narrow implants, the other side of the dimensional coin, held their own where it counts. The split-mouth trial of 3.3 mm versus standard fixtures recorded no failures in either arm and near-identical marginal bone loss (MBL) at 4.2 years: 0.83 versus 0.87 mm, not significant. The posterior meta-analysis of narrow-diameter implants (NDIs, under 3.75 mm) pooled 97.7% survival across 2,741 implants. The wide-implant series reported 3.77% failure over a mean 6.3 years with 0.89 mm of bone loss. Different diameters, same broad message: the bone copes.
Where They Agree, and Where They Argue
The agreement is the useful part. Survival is robust across short and narrow geometries, and the residual risk has relocated to the prosthetic interface. The split-mouth trial makes this almost literal: zero biological failures, but every technical complication landed on the narrow side, one abutment screw fracture (2%) and two screw looseners (4%). The diameter-complications meta-analysis says the same thing from 18 studies: overall mechanical risk does not track diameter, and narrow implants actually fractured abutments less than standard ones (relative risk 0.17, 95% confidence interval 0.06–0.45). The screw is the weak link, not the osseointegration.
The arguments are instructive rather than fatal. Stability metrics fall out: the short-wide bench study found short implants superior on insertion torque and Periotest yet inferior on the implant stability quotient (ISQ), while the finite element study found ISQ rising obediently with length. Resonance frequency analysis (RFA), in other words, is a poor solo witness for a short implant; torque and the device disagree, and the device is the one that blinks. The “short versus long” framing also bends under pressure. Block still shows long implants numerically safest at 1.9%, while the bench data argue a short wide implant outperforms a conventional narrow-long one. Both can be true, because the variable doing the work is diameter, not length. Width is buying back the stability that the missing millimetres gave away.
Key Findings
- Splinting is the highest-yield decision for a short implant. Failure fell from 7.3% to 4.3% clinically, and micromotion dropped significantly for 4 mm implants mechanically. If the restorative design permits a splint, that is where the risk reduction lives.
- Choose width before you choose a graft. A short wide implant generated markedly higher insertion torque than a conventional one in both dense and soft bone, which reframes vertical augmentation as a choice rather than an obligation in the atrophic posterior ridge.
- Narrow is not fragile. A 3.3 mm implant matched standard fixtures for bone and survival at 4.2 years, and pooled posterior NDI survival reached 97.7%. The anxiety has outrun the data.
- The complication is mechanical, not biological. Screw loosening and abutment fracture, not bone loss, dominate the adverse events; plan the prosthesis as the thing most likely to grumble.
- Read ISQ with suspicion on short implants. It disagreed with insertion torque and Periotest on exactly the implants where you most want a straight answer. Treat a low number as a poor witness, not a verdict.
- The honest caveat. Most of the mechanical evidence is in vitro (bovine rib, polyurethane foam), and the strongest splinting signal comes from an analytical review rather than a randomised trial. The direction is consistent across designs; the precision is not.
💡 The Clinical Bottom Line
If you place a short or narrow implant on Monday, design backwards from its weakest point. Splint it to a neighbour where the prosthesis allows, because that is the one move the evidence repeatedly rewards. When the ridge is short but wide enough, reach for diameter before you reach for a bone graft. And when the resonance frequency device returns a disappointing number on a 6 mm implant that torqued to 40 Ncm, believe the torque. The bone, it turns out, was never the part you needed to worry about. The screw was, and the screw has been telling us so for years.
Clinical Relevance
Short and narrow implants are not compromised long implants; they are different structural objects whose risk has shifted to the prosthetic interface. Splint short implants where the restorative design allows, prefer width over length before reaching for a vertical graft, and do not let a single low stability reading on a short implant overrule an adequate insertion torque.
Disclosure: The author has no financial conflicts of interest related to the products or topics discussed in this review. This is an independent summary prepared for educational purposes.
Continue the conversation
This article is also published on Substack, where you can leave comments and join the discussion.
Read on Substack →